-
龚学忠：新冠肺炎合并急性肾损伤
2020-04-28 32709 看过 免费 -
第一期：新形势下的肿瘤合理用药管理
话题一：从政策更新谈肿瘤合理用药的管理话题二：解读2019版新型抗肿瘤药物临床应用指导原则话题三：免疫治疗合理用药的挑战和解决之道
2020-04-28 27149 看过 免费 -
【关爱肾脏，合理用药】线上会议
2020-04-28 39060 看过 免费 -
悉听我说 第四期
2020-04-27 26645 看过 免费 -
悉听我说 第三期
狼疮性肾炎规范化诊疗的探讨
2020-04-25 28640 看过 免费 -
悉听我说第二期
2020-04-24 27409 看过 免费 -
第六期 中西医结合疾病管理“心”模式
2020-04-23 52251 看过 免费 -
空中对话系列|第三期
协办单位：中国医学论坛报社
2020-04-23 26159 看过 免费 -
CMT introudctions
China Medical Tribune was founded in 1983. It is a professional medical media co-founded by the former Ministry of Health and Sackler Foundation. It is a public institution under the Center for International Exchange and Cooperation, National Health Commission. CMT adheres to the spirit of dedication, innovation and responsibility. It is committed to conveying the advances and attracting fields of studies in medical science and clinical practice at home and abroad to 2 million Chinese doctors in the principle of evidence-based reporting methods; and it also provides the latest medical information and solutions to clinical problems. CMT listens to different academic voices and delivers objective medical information to Chinese clinical workers. It is currently one of the largest and most influential professional medical newspaper in China. In addition to the newspaper business, it also covers the scope of online media platforms, including its one and only official medical education-based application CMTopDr, the matrix of wechat public accounts and customized platforms for live conference broadcasting, surveys and collection of real-world medical records.
2020-04-23 14900 看过 免费 -
悉听我说第一期
2020-04-22 28111 看过 免费
直播预告
热门资讯
- 全球品质，本地供应——舒万诺首款国产光固化复合树脂获证上市，加速中国口腔健康服务升级
- 思享•华山（第5期）预告 | 启程在治疗结束后：肿瘤长期生存者的人文关怀
- 【病例解读】氨曲南-阿维巴坦成功治疗产MBL的KP所致重症HAP患者
- 精准抗感染专项典型病例专栏：神经外科术后多重耐药菌感染诊疗策略
- 93 岁老伯 MBL-CRE感染致反复发热，新型酶抑制剂用药 7 天感染指标转阴!
- 肝移植术后患者为何高热不退？专家分享实战病例！
- 【会议通知】9月17日 |领航计划·守望阳光——精神心理专科临床管理路径优化与创新医疗服务项目
- 吴文育教授：填补TYK2抑制剂治疗难治性LPP空白丨EADV2025中国之声
- 非奈利酮心肾保护新策略：聚焦炎症与纤维化，立足中国循证
- 新生儿胸部X线影像诊断
